Paul J Clancy Insider Trading $IDPH BIOGEN INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul J Clancy.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul J Clancy. Paul J Clancy is Executive VP and CFO in BIOGEN INC. ($IDPH).
Paul J Clancy in BIOGEN INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Paul J Clancy: Executive VP and CFO
Holdings: 7,087 shares
Latest Transaction: Sep 19 2013
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Paul J Clancy in BIOGEN INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 19 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 49.65 | 26,785 | 1,329,875 | 0 | |
| Sep 19 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 245.00 | 26,785 | 6,562,325 | 7,087 | 33.9 K to 7.1 K (-79.08 %) |
| Sep 19 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 49.65 | 26,785 | 1,329,875 | 33,872 | 7.1 K to 33.9 K (+377.95 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 60.56 | 43,940 | 2,661,006 | 0 | |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 63.55 | 20,000 | 1,271,000 | 0 | |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 49.31 | 18,100 | 892,511 | 0 | |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 41.03 | 6,000 | 246,180 | 0 | |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 44.24 | 10,990 | 486,198 | 0 | |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 239.75 | 9,098 | 2,181,282 | 7,087 | 16.2 K to 7.1 K (-56.21 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 238.56 | 11,134 | 2,656,172 | 16,185 | 27.3 K to 16.2 K (-40.76 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 237.93 | 14,708 | 3,499,519 | 27,319 | 42 K to 27.3 K (-35.00 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 236.94 | 9,000 | 2,132,487 | 42,027 | 51 K to 42 K (-17.64 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 60.56 | 43,940 | 2,661,006 | 51,027 | 7.1 K to 51 K (+620.01 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 239.76 | 3,970 | 951,835 | 7,087 | 11.1 K to 7.1 K (-35.90 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 238.65 | 4,300 | 1,026,186 | 11,057 | 15.4 K to 11.1 K (-28.00 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 238.00 | 7,503 | 1,785,699 | 15,357 | 22.9 K to 15.4 K (-32.82 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 236.99 | 4,227 | 1,001,748 | 22,860 | 27.1 K to 22.9 K (-15.61 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 63.55 | 20,000 | 1,271,000 | 27,087 | 7.1 K to 27.1 K (+282.21 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 239.79 | 3,210 | 769,736 | 7,087 | 10.3 K to 7.1 K (-31.17 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 238.80 | 3,269 | 780,644 | 10,297 | 13.6 K to 10.3 K (-24.10 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 238.12 | 7,221 | 1,719,493 | 13,566 | 20.8 K to 13.6 K (-34.74 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 237.05 | 4,400 | 1,043,029 | 20,787 | 25.2 K to 20.8 K (-17.47 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 49.31 | 18,100 | 892,511 | 25,187 | 7.1 K to 25.2 K (+255.40 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 240.20 | 100 | 24,020 | 7,087 | 7.2 K to 7.1 K (-1.39 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 239.54 | 1,475 | 353,317 | 7,187 | 8.7 K to 7.2 K (-17.03 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 238.29 | 2,825 | 673,175 | 8,662 | 11.5 K to 8.7 K (-24.59 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 237.05 | 1,600 | 379,278 | 11,487 | 13.1 K to 11.5 K (-12.23 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 41.03 | 6,000 | 246,180 | 13,087 | 7.1 K to 13.1 K (+84.66 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 239.84 | 1,800 | 431,716 | 7,087 | 8.9 K to 7.1 K (-20.25 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 239.00 | 1,525 | 364,481 | 8,887 | 10.4 K to 8.9 K (-14.65 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 238.12 | 5,165 | 1,229,879 | 10,412 | 15.6 K to 10.4 K (-33.16 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 237.05 | 2,500 | 592,615 | 15,577 | 18.1 K to 15.6 K (-13.83 %) |
| Sep 18 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 44.24 | 10,990 | 486,198 | 18,077 | 7.1 K to 18.1 K (+155.07 %) |
| May 01 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 226.01 | 900 | 203,407 | 7,087 | 8 K to 7.1 K (-11.27 %) |
| May 01 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 225.40 | 6,241 | 1,406,696 | 7,987 | 14.2 K to 8 K (-43.86 %) |
| May 01 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 224.34 | 5,380 | 1,206,972 | 14,228 | 19.6 K to 14.2 K (-27.44 %) |
| May 01 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 222.57 | 1,968 | 438,016 | 19,608 | 21.6 K to 19.6 K (-9.12 %) |
| May 01 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 219.71 | 9,123 | 2,004,414 | 21,576 | 30.7 K to 21.6 K (-29.72 %) |
| Feb 26 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 4,281 | 0 | 4,280 | |
| Feb 26 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 164.40 | 2,021 | 332,252 | 30,699 | 32.7 K to 30.7 K (-6.18 %) |
| Feb 26 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 4,281 | 0 | 32,720 | 28.4 K to 32.7 K (+15.05 %) |
| Feb 14 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | A | 0.00 | 11,229 | 0 | 11,229 | |
| Feb 12 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 4,692 | 0 | 9,382 | |
| Feb 12 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | J | 0.00 | 426 | 0 | 9,576 | |
| Feb 12 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 2,765 | 0 | 10,002 | |
| Feb 12 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 164.44 | 1,731 | 284,646 | 28,439 | 30.2 K to 28.4 K (-5.74 %) |
| Feb 12 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 4,692 | 0 | 30,170 | 25.5 K to 30.2 K (+18.42 %) |
| Feb 12 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 164.44 | 899 | 147,832 | 25,478 | 26.4 K to 25.5 K (-3.41 %) |
| Feb 12 2013 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 2,765 | 0 | 26,377 | 23.6 K to 26.4 K (+11.71 %) |
| Feb 27 2012 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 4,281 | 0 | 8,561 | |
| Feb 27 2012 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 116.39 | 1,400 | 162,946 | 23,612 | 25 K to 23.6 K (-5.60 %) |
| Feb 27 2012 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 116.39 | 1,386 | 161,317 | 25,012 | 26.4 K to 25 K (-5.25 %) |
| Feb 27 2012 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 116.70 | 1,786 | 208,426 | 26,398 | 28.2 K to 26.4 K (-6.34 %) |
| Feb 27 2012 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 4,281 | 0 | 28,184 | 23.9 K to 28.2 K (+17.91 %) |
| Feb 13 2012 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 4,692 | 0 | 14,074 | |
| Feb 13 2012 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 117.78 | 1,957 | 230,495 | 23,903 | 25.9 K to 23.9 K (-7.57 %) |
| Feb 13 2012 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 4,692 | 0 | 25,860 | 21.2 K to 25.9 K (+22.17 %) |
| Feb 10 2012 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | A | 0.00 | 12,767 | 0 | 12,767 | |
| Feb 03 2012 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 67.57 | 8,400 | 567,588 | 0 | |
| Feb 03 2012 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 43.50 | 13,000 | 565,500 | 0 | |
| Feb 03 2012 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 120.00 | 8,400 | 1,008,000 | 21,168 | 29.6 K to 21.2 K (-28.41 %) |
| Feb 03 2012 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 120.00 | 13,000 | 1,560,000 | 29,568 | 42.6 K to 29.6 K (-30.54 %) |
| Feb 03 2012 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 67.57 | 8,400 | 567,588 | 42,568 | 34.2 K to 42.6 K (+24.58 %) |
| Feb 03 2012 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 43.50 | 13,000 | 565,500 | 34,168 | 21.2 K to 34.2 K (+61.41 %) |
| Jan 04 2012 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 112.69 | 5,574 | 628,144 | 21,168 | 26.7 K to 21.2 K (-20.84 %) |
| Jan 04 2012 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 112.22 | 14,670 | 1,646,257 | 26,742 | 41.4 K to 26.7 K (-35.42 %) |
| Aug 03 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 102.90 | 835 | 85,922 | 41,412 | 42.2 K to 41.4 K (-1.98 %) |
| Apr 29 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 49.03 | 4,761 | 233,432 | 0 | |
| Apr 29 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 37.45 | 10,005 | 374,687 | 0 | |
| Apr 29 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 99.69 | 90 | 8,972 | 42,247 | 42.3 K to 42.2 K (-0.21 %) |
| Apr 29 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 99.12 | 485 | 48,075 | 42,337 | 42.8 K to 42.3 K (-1.13 %) |
| Apr 29 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 98.86 | 1,657 | 163,814 | 42,822 | 44.5 K to 42.8 K (-3.73 %) |
| Apr 29 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 99.36 | 290 | 28,814 | 44,479 | 44.8 K to 44.5 K (-0.65 %) |
| Apr 29 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 98.83 | 1,263 | 124,819 | 44,769 | 46 K to 44.8 K (-2.74 %) |
| Apr 29 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 99.36 | 291 | 28,914 | 46,032 | 46.3 K to 46 K (-0.63 %) |
| Apr 29 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 98.75 | 874 | 86,308 | 46,323 | 47.2 K to 46.3 K (-1.85 %) |
| Apr 29 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 99.27 | 700 | 69,492 | 47,197 | 47.9 K to 47.2 K (-1.46 %) |
| Apr 29 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 98.83 | 4,061 | 401,341 | 47,897 | 52 K to 47.9 K (-7.82 %) |
| Apr 29 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 49.03 | 4,761 | 233,432 | 51,958 | 47.2 K to 52 K (+10.09 %) |
| Apr 29 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 99.28 | 1,300 | 129,058 | 47,197 | 48.5 K to 47.2 K (-2.68 %) |
| Apr 29 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 98.85 | 8,705 | 860,481 | 48,497 | 57.2 K to 48.5 K (-15.22 %) |
| Apr 29 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 37.45 | 10,005 | 374,687 | 57,202 | 47.2 K to 57.2 K (+21.20 %) |
| Apr 08 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 58.99 | 28,750 | 1,695,963 | 0 | |
| Apr 08 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 71.15 | 25,888 | 1,841,931 | 47,197 | 73.1 K to 47.2 K (-35.42 %) |
| Apr 08 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 58.99 | 28,750 | 1,695,963 | 73,085 | 44.3 K to 73.1 K (+64.85 %) |
| Feb 28 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 67.26 | 1,066 | 71,699 | 44,335 | 45.4 K to 44.3 K (-2.35 %) |
| Feb 28 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 67.26 | 1,098 | 73,851 | 45,401 | 46.5 K to 45.4 K (-2.36 %) |
| Feb 25 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | J | 0.00 | 760 | 0 | 12,842 | |
| Feb 25 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 667 | 0 | 13,602 | |
| Feb 25 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 2,854 | 0 | 14,269 | |
| Feb 25 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 66.76 | 212 | 14,153 | 46,499 | 46.7 K to 46.5 K (-0.45 %) |
| Feb 25 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 66.76 | 907 | 60,551 | 46,711 | 47.6 K to 46.7 K (-1.90 %) |
| Feb 25 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 667 | 0 | 47,618 | 47 K to 47.6 K (+1.42 %) |
| Feb 25 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 2,854 | 0 | 46,951 | 44.1 K to 47 K (+6.47 %) |
| Feb 15 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 65.83 | 1,686 | 110,989 | 44,097 | 45.8 K to 44.1 K (-3.68 %) |
| Feb 11 2011 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | A | 0.00 | 18,766 | 0 | 18,766 | |
| Sep 07 2010 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 56.24 | 1,114 | 62,651 | 45,783 | 46.9 K to 45.8 K (-2.38 %) |
| Aug 03 2010 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 55.88 | 835 | 46,660 | 46,897 | 47.7 K to 46.9 K (-1.75 %) |
Page: 1